Sequencing multiple myeloma therapies with and after antibody therapies

von van de Donk, Niels W. C. J.
Veröffentlicht in Hematology Am Soc Hematol Educ Program (2020)

Brentuximab vedotin

von van de Donk, Niels W. C.J., Dhimolea, Eugen
Veröffentlicht 2012

Trogocytosis represents a novel mechanism of action of daratumumab in multiple myeloma

von Krejcik, Jakub, van de Donk, Niels W.C.J.
Veröffentlicht in Oncotarget (2018)

CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance

von van de Donk, Niels W.C.J., Usmani, Saad Z.
Veröffentlicht in Front Immunol (2018)

Editorial: Exploiting the Immune System to Treat Multiple Myeloma: From Transplantation to Novel Treatment Approaches

von van de Donk, Niels W. C. J., Kastritis, Efstathios, Gay, Francesca
Veröffentlicht in Front Oncol (2020)

Monoclonal Antibodies and Antibody Drug Conjugates in Multiple Myeloma

von Radocha, Jakub, van de Donk, Niels W. C. J., Weisel, Katja
Veröffentlicht in Cancers (Basel) (2021)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?

von Plesner, Torben, van de Donk, Niels W. C. J., Richardson, Paul G.
Veröffentlicht in Cells (2020)

Should all newly diagnosed MM patients receive CD38 antibody–based treatment?

von Korst, Charlotte L. B. M., van de Donk, Niels W. C. J.
Veröffentlicht in Hematology Am Soc Hematol Educ Program (2020)

Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update

von Nijhof, Inger S., van de Donk, Niels W. C. J., Zweegman, Sonja, Lokhorst, Henk M.
Veröffentlicht in Drugs (2017)

Targeted Therapy With Immunoconjugates for Multiple Myeloma

von Bruins, Wassilis S. C., Zweegman, Sonja, Mutis, Tuna, van de Donk, Niels W. C. J.
Veröffentlicht in Front Immunol (2020)

Dual Targeting to Overcome Current Challenges in Multiple Myeloma CAR T-Cell Treatment

von van der Schans, Jort J., van de Donk, Niels W. C. J., Mutis, Tuna
Veröffentlicht in Front Oncol (2020)

Immunotherapy in myeloma: how far have we come?

von Franssen, Laurens E., Mutis, Tuna, Lokhorst, Henk M., van de Donk, Niels W. C. J.
Veröffentlicht in Ther Adv Hematol (2019)

How I treat plasma cell leukemia

von van de Donk, Niels W. C. J., Lokhorst, Henk M., Anderson, Kenneth C., Richardson, Paul G.
Veröffentlicht 2012

Cytomegalovirus Reactivation in a Patient With Extensively Pretreated Multiple Myeloma During Daratumumab Treatment

von Frerichs, Kristine A., Bosman, Patricia W.C., Nijhof, Inger S., Zweegman, Sonja, van de Donk, Niels W.C.J.
Veröffentlicht in Clin Lymphoma Myeloma Leuk (2019)

Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma

von Franssen, Laurens E., Stege, Claudia A. M., Zweegman, Sonja, van de Donk, Niels W. C. J., Nijhof, Inger S.
Veröffentlicht in J Clin Med (2020)

First-line treatment and survival of newly diagnosed primary plasma cell leukemia patients in the Netherlands: a population-based study, 1989-2018

von Brink, Mirian, Visser, Otto, Zweegman, Sonja, Sonneveld, Pieter, Broyl, Annemiek, van de Donk, Niels W.C.J., Dinmohamed, Avinash G.
Veröffentlicht in Blood Cancer J (2021)

Primary cardiac lymphoma with central nervous system relapse

von van Rooijen, Cleo R., Scholtens, Asbjorn M., de Jong, C. Niels, Saraber, Colette E., van de Donk, Niels W. C. J.
Veröffentlicht in Clin Case Rep (2017)

Feasibility of controlling CD38-CAR T cell activity with a Tet-on inducible CAR design

von Drent, Esther, Poels, Renée, Mulders, Manon J., van de Donk, Niels W. C. J., Themeli, Maria, Lokhorst, Henk M., Mutis, Tuna
Veröffentlicht in PLoS One (2018)

CD38-targeted therapy with daratumumab reduces autoantibody levels in multiple myeloma patients

von Frerichs, Kristine A., Verkleij, Christie P.M., Bosman, Patricia W.C., Zweegman, Sonja, Otten, Henny, van de Donk, Niels W.C.J.
Veröffentlicht in J Transl Autoimmun (2019)

Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma

von Schmitz, Marian F., Otten, Henny G., Franssen, Laurens E., van Dorp, Suzanne, Strooisma, Theo, Lokhorst, Henk M., van de Donk, Niels W.C.J.
Veröffentlicht in Haematologica (2014)